Company Analysis

Upstream Bio, Inc. (UPB)

Nasdaq: UPB · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2024
Grade5.8
◀ Past 4.2● Present 6.5▶ Future 6.1
3 est.

Who runs Upstream Bio, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Sutherland Everett Rand
Chief Executive Officer. First filing Oct 2024, latest Sep 17, 2026, 3 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
15 people on the record since 2024
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Sutherland Everett RandChief Executive OfficerOct 2024Sep 17, 20263 · $0.00
Gray MichaelCFO and COOOct 2024Sep 17, 20263 · $0.00
Deykin AaronChief Medical OfficerOct 2024Sep 17, 20263 · $0.00
Houghton AdamChief Business OfficerOct 2024Sep 17, 20263 · $0.00
Ambrose AllisonGeneral CounselDec 2024Sep 17, 20263 · $0.00
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Beckman DanielladirectorOct 2024Jun 11, 2026none
Chimovits ErezdirectorOct 2024Jun 11, 2026none
Fleming Harold EdwarddirectorOct 2024Jun 11, 2026none
Ratcliffe LiamdirectorOct 2024Jun 11, 2026none
Renaud Ronald C JrdirectorOct 2024Jun 11, 2026none
Ruddy Marcella K.directorOct 2024Jun 11, 2026none
Earlier names on the record10, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton UPB · research, not advice